Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain health diseases, excluding the Republic

FORT WASHINGTON, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) — Coventry, the leader and creator of the secondary market for life insurance, is proud to recognize Life Insurance Awareness Month by

Louis Cooper Chief Commercial Officer Axi ( CCO) Louis Cooper Chief Commercial Officer Axi ( CCO) SYDNEY, Sept. 22, 2025 (GLOBE NEWSWIRE) — Axi, a leading global online trading and